The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 30, 2009

Filed:

Feb. 13, 2006
Applicants:

Cathryn M. Clary, New York, NY (US);

Jeroen Van Beek, Ridgefield, CT (US);

Perry S. Eisman, Southamton, NY (US);

Sean Donevan, Dexter, MI (US);

Atul Pande, East Lyme, CT (US);

Richard Kavoussi, Ann Arbor, MI (US);

Lyou-fu MA, Ann Arbor, MI (US);

Inventors:

Cathryn M. Clary, New York, NY (US);

Jeroen Van Beek, Ridgefield, CT (US);

Perry S. Eisman, Southamton, NY (US);

Sean Donevan, Dexter, MI (US);

Atul Pande, East Lyme, CT (US);

Richard Kavoussi, Ann Arbor, MI (US);

Lyou-Fu Ma, Ann Arbor, MI (US);

Assignee:

Indevus Pharmaceuticals, Inc., Lexington, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4745 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention provides methods for treating social anxiety disorder, comprising administering 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone or 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-5-hydroxy-2-oxohexyl) -1-isoindolinone or pharmaceutically acceptable salt, or optical isomer therof, and optionally comprising administering another compound for the treatment of social anxiety disorder that is a GABA agonist.


Find Patent Forward Citations

Loading…